Over the last five years, demand for cannabidiol (CBD) and related whole-plant hemp extracts has grown exponentially. Colorado-based Hemp Business Journal estimates the total CBD industry—including both hemp and marijuana-derived sources—grew to $360 million in U.S. sales in 2017, reflecting a 37 percent growth rate. Despite the surging demand for hemp-derived products, the CBD industry continues to face myriad challenges. In this three-hour workshop, leading hemp executives and attorneys will review the current landscape for CBD and strategies to mature as an industry and overcome hurdles to growth.
Industry experts will discuss and debate:
- Raising capital and transacting business with financial institutions
- Evolution of product formulations and how to reach new distribution channels
- Implications of Hemp Industry Association’s lawsuit against DEA over its marijuana extract rule;
- Regulatory considerations including the Hemp Farming Act of 2018, GW Pharma, state initiatives and DSHEA
Todd Harrison, Partner and Co-Chair, Food and Drug Law Practice, Venable LLP
Tim Gordon, Functional Remedies
Bob Hoban, Hoban Law Group
Jim Prochnow, Greenberg Traurig
Ashish Talati, Amin Talati Upadhye
Stuart Tomc, CV Sciences Inc
Visit the event page for more information about this event and to register.
© 2018 Venable LLP. Using, distributing, possessing, and/or selling marijuana is illegal under existing federal law. Compliance with state law does not guarantee or constitute compliance with federal law. This informational overview is not intended to provide any legal advice or any guidance or assistance in violating federal law.